Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
D Williams Parsons, Katherine A Janeway, David R Patton, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
Cancers
|
November 13, 2025
Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia
Priyatharsini Nirmalanantham, Andrés E Quesada, Anindita Ghosh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Roberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
Frontiers in Oncology
|
February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Sarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Clinical Chemistry
|
January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumors
Ken Chen, Funda Meric-Bernstam, Hao Zhao, et al.
The American Journal of Surgical Pathology
|
February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases
Mariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting
Jeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
D Williams Parsons, Katherine A Janeway, David R Patton, et al.
American Journal of Clinical Pathology
|
October 22, 2015
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing
Sinchita Roy-Chowdhuri, Debora de Melo Gagliato, Mark J Routbort, et al.
American Journal of Hematology
|
March 1, 2020
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, et al.
Cancers
|
November 13, 2025
Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia
Priyatharsini Nirmalanantham, Andrés E Quesada, Anindita Ghosh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 14, 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Roberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
Frontiers in Oncology
|
February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Sarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Clinical Chemistry
|
January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumors
Ken Chen, Funda Meric-Bernstam, Hao Zhao, et al.
The American Journal of Surgical Pathology
|
February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases
Mariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting
Jeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.
Page
of 18